What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His primary areas of investigation include Leukemia, Cancer research, Genetics, Mutation and Internal medicine.
His Leukemia research is under the purview of Immunology.
His Cancer research study integrates concerns from other disciplines, such as Epigenetics, Regulation of gene expression, microRNA and GATA1.
His studies in Mutation integrate themes in fields like Embryonic stem cell, Xenopus, Anatomy, Molecular biology and Acute lymphocytic leukemia.
His research integrates issues of Oncology and Locus in his study of Internal medicine.
Shai Izraeli interconnects Chromosome breakage and Gene rearrangement in the investigation of issues within Acute leukemia.
His most cited work include:
- Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration (410 citations)
- The MLL recombinome of acute leukemias in 2013 (344 citations)
- New insights to the MLL recombinome of acute leukemias (327 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Cancer research, Leukemia, Immunology, Internal medicine and Genetics.
His studies deal with areas such as Haematopoiesis, STAT5, Acute lymphocytic leukemia and B cell as well as Cancer research.
His specific area of interest is Leukemia, where Shai Izraeli studies Acute leukemia.
His Immunology study combines topics in areas such as Down syndrome and Somatic cell.
His Internal medicine study incorporates themes from Gastroenterology and Oncology.
His Gene study combines topics from a wide range of disciplines, such as Molecular biology and Cell biology.
He most often published in these fields:
- Cancer research (49.31%)
- Leukemia (44.10%)
- Immunology (30.90%)
What were the highlights of his more recent work (between 2015-2021)?
- Leukemia (44.10%)
- Cancer research (49.31%)
- Internal medicine (19.10%)
In recent papers he was focusing on the following fields of study:
Shai Izraeli mostly deals with Leukemia, Cancer research, Internal medicine, Haematopoiesis and Immunology.
He is studying Acute leukemia, which is a component of Leukemia.
His Cancer research research is multidisciplinary, incorporating perspectives in Cancer cell, B cell, STAT5, Stem cell and Kinase.
Shai Izraeli combines subjects such as Molecular genetics and Oncology with his study of Internal medicine.
His Haematopoiesis research incorporates elements of Progenitor cell and Germline mutation.
His study in Immunology is interdisciplinary in nature, drawing from both Down syndrome and Somatic cell.
Between 2015 and 2021, his most popular works were:
- The MLL recombinome of acute leukemias in 2017 (231 citations)
- The MLL recombinome of acute leukemias in 2017 (231 citations)
- The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice (164 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Leukemia, Cancer research, Genetics, Immunology and Mutation are his primary areas of study.
He is interested in Acute leukemia, which is a field of Leukemia.
The various areas that Shai Izraeli examines in his Cancer research study include Cancer cell, Cancer genome and Gene mutation.
His Genetics research is multidisciplinary, relying on both Computational biology and Tumor cells.
The study incorporates disciplines such as Down syndrome, Disease and Toxicity in addition to Immunology.
His research in the fields of Missense mutation overlaps with other disciplines such as Glucosamine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
